Kluin-Nelemans, Hanneke C.
Reiter, Andreas
Illerhaus, Anja
van Anrooij, Bjorn
Hartmann, Karin
Span, Lambertus F. R.
Gorska, Aleksandra
Niedoszytko, Marek
Lange, Magdalena
Scaffidi, Luigi
Zanotti, Roberta
Bonadonna, Patrizia
Perkins, Cecelia
Elena, Chiara
Malcovati, Luca
Shoumariyeh, Khalid
von Bubnoff, Nikolas
Parente, Roberta
Triggiani, Massimo
Schwaab, Juliana
Jawhar, Mohamad
Caroppo, Francesca
Fortina, Anna Belloni
Brockow, Knut
Zink, Alexander
Fuchs, David
Kilbertus, Alex
Yavuz, Akif Selim
Doubek, Michael
Mattsson, Mattias
Hagglund, Hans
Panse, Jens
Sabato, Vito
Aberer, Elisabeth
Niederwieser, Dietger http://orcid.org/0000-0002-4737-1103
Breynaert, Christine
Várkonyi, Judit
Kennedy, Vanessa
Lortholary, Olivier
Jakob, Thilo
Hermine, Olivier
Rossignol, Julien
Arock, Michel
Gotlib, Jason
Valent, Peter
Sperr, Wolfgang R.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (RA2838)
Article History
Received: 28 June 2019
Revised: 14 October 2019
Accepted: 3 November 2019
First Online: 18 November 2019
Compliance with ethical standards
:
: HCK-N: institutional financial support from Novartis to perform a phase II trial with midostaurin. WRS: honoraria from Novartis, Pfizer, AbbVie, Daiichi Sankyo, Amgen, Thermo Fisher, Deciphera, Incyte, Celgene, and Jazz. BvA: financial support from Novartis for research and advisory boards. KH: research grant: Euroimmun Lectures, and consulting: ALK, Blueprint, Deciphera, and Novartis. CE, DF, and JR: advisory board Novartis. KS: travel expenses from Novartis. NvB: institutional financial support from Novartis. MT: advisory board/honoraria: Deciphera and Novartis. JP: funding to support conduct of clinical trial: Blueprint Medicines and Deciphera; advisory board/honoraria: Blueprint Medicines and Novartis. OH: research funding support from AB science and Novartis. Advisory board of AB science. JG: funding to support conduct of clinical trial: Blueprint Medicines and Deciphera; advisory board/honoraria: Blueprint Medicines, Deciphera, and Allakos. VS is a senior clinical researcher of the Research Foundation Flanders/Fonds Wetenschappelijk Onderzoek (FWO: 1804518N).